Keywords: Dainippon Sumitomo, Nippon Shanyaku, AMP-986, Overactive bladder, License, Japan

Dainippon Sumitomo partners with Nippon Shinyaku for urology drug AMP-986

Article | 12 March 2013

Japanese drugmakers Dainippon Sumitomo Pharma (TYO: 4506) and Nippon Shinyaku (TYO: 4516) have concluded a license agreement for exclusive rights to develop, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Nippon Shinyaku

Dainippon Sumitomo Pharma

Go to company listing

Related Drugs

AMP-986

Go to drug listing